Hyoscine Butyl Bromide

# Hyoscine butyl bromide ## Overview - **Classification**: Antispasmodic, Anticholinergic (Muscarinic antagonist). - **Mechanism**: Acts locally on smooth muscle M-receptors of GI, biliary, and genitourinary tracts. Reduces muscle spasm and associated pain by blocking acetylcholine. Minimal CNS effects due to poor blood-brain barrier penetration. ## Primary Indications 1. **Gastrointestinal Spasm**: Relief of spasm in conditions like Irritable Bowel Syndrome (IBS), diverticulitis, gastroenteritis. 2. **Renal/Biliary Colic**: Adjunctive treatment for painful spasms. 3. **Diagnostic Procedures**: To reduce gastrointestinal motility during endoscopy, colonoscopy, or radiological imaging. ## Adult Dosing ### Standard Dosing **Gastrointestinal Spasm (Oral)** - **Dose**: **10-20 mg** - **Frequency**: **3-5 times a day** - **Route**: Oral - **Duration**: As needed, typically short-term. **Acute Spasm/Diagnostic Procedures (Parenteral)** - **Dose**: **20 mg** - **Frequency**: Can repeat after **30 minutes** if needed. - **Route**: Slow IV injection or IM injection. - **Maximum**: Total daily dose **100 mg**. ### Dose Adjustments - **Renal Impairment**: No specific dose adjustments recommended. Use with caution; monitor for increased anticholinergic effects. - **Hepatic Impairment**: No specific dose adjustments recommended. Use with caution. - **Elderly Patients**: Use with caution, start at lower end of dose range. Increased susceptibility to anticholinergic side effects (e.g., dry mouth, urinary retention, constipation, blurred vision). ## Pediatric Dosing ### Neonates (0-28 days) - **Not recommended**. Insufficient safety and efficacy data. - **Special Notes**: Risk of serious adverse effects including paradoxical excitation and respiratory depression. ### Infants (1-12 months) - **Not recommended** for routine use. - **Special Notes**: Use only under strict specialist supervision for specific diagnostic procedures if no alternative. Close monitoring is essential. ### Children (1-6 years) - **Oral (for spasm)**: **Not generally recommended** for routine use. If prescribed by specialist: **5-10 mg** up to **3 times a day**. - **Parenteral (for procedures, under specialist)**: **0.3-0.6 mg/kg/dose** IV/IM. - **Maximum (Parenteral)**: Total daily dose **1.5 mg/kg** or **100 mg**, whichever is lower. - **Special Notes**: Use with extreme caution. Closely monitor for anticholinergic effects (tachycardia, urinary retention, flushed skin). ### Children (6-12 years) - **Oral (for spasm)**: **10-20 mg** up to **3 times a day**. - **Parenteral (for acute spasm/procedures)**: **0.3-0.6 mg/kg/dose** IV/IM. Max **20 mg/dose**. - **Maximum (Parenteral)**: Total daily dose **1.5 mg/kg** or **100 mg**, whichever is lower. ### Adolescents (13-18 years) - **Dose**: Generally follows **adult dosing**. - **Maximum**: Oral: **20 mg** up to **5 times a day**. Parenteral: Total daily max **100 mg**. ## Safety Information ### Contraindications - **Absolute**: Myasthenia Gravis, Untreated Narrow-Angle Glaucoma. - **Absolute**: Mechanical Stenosis of GI Tract (e.g., pyloric stenosis, paralytic ileus, megacolon). - **Absolute**: Urinary retention due to prostatic hypertrophy or other uropathies. - **Absolute**: Tachyarrhythmia. - **Absolute**: Hypersensitivity to hyoscine butyl bromide or excipients. ### Common Adverse Effects - **Very Common (>10%)**: Dry mouth. - **Common (1-10%)**: Tachycardia, dizziness, blurred vision, accommodation disturbances, constipation, urinary retention, sweating disturbances. - **Serious but Rare**: Anaphylactic shock, acute angle-closure glaucoma, paradoxical excitation (especially in children/elderly). ### Key Drug Interactions - **Tricyclic Antidepressants, Antihistamines, Antipsychotics, Quinidine, Disopyramide**: Potentiate anticholinergic effects (increased risk of dry mouth, urinary retention, blurred vision). - **Beta-agonists (e.g., salbutamol)**: Increased heart rate. Use with caution. - **Dopamine Antagonists (e.g., metoclopramide, domperidone)**: Hyoscine butyl bromide may reduce their prokinetic effect. ## Monitoring & Follow-up - **Before Treatment**: Assess for pre-existing conditions like glaucoma, prostatic hypertrophy. - **During Treatment**: Monitor for symptom relief and onset of anticholinergic side effects. - **Clinical Signs**: Watch for acute eye pain or vision loss (potential acute glaucoma, seek immediate medical attention). Monitor for signs of urinary retention or worsening constipation. ## Clinical Pearls - 💡 **Tip 1**: Oral form is typically taken **before meals** for optimal effect on GI spasm. - 💡 **Tip 2**: Advise patients about potential **blurred vision** and **drowsiness**; caution with driving or operating machinery. - 💡 **Tip 3**: Parenteral form provides **rapid relief** for acute spasms or during diagnostic procedures. Administer IV slowly. - 💡 **Tip 4**: Not effective for pain caused by inflammation or non-spasmodic conditions. - 💡 **Tip 5**: For patients with suspected prostatic hypertrophy, monitor closely for signs of urinary retention. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.